Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Oric Pharmaceuticals (ORIC) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Docetaxel, Enzalutamide, Darolutamide, Rinzimetostat, Taxotere, Oric-944Metastatic Castration Resistant Prostate CancerPhase IIIRecruitingA Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)Jun 18, 2026―
Oric-114 Dose 1 + Amivantamab, Oric-114 Dose 2 + Amivantamab, Oric-114 Dose 3 + AmivantamabSolid Tumors, Nsclc, Egfr Exon 20 Insertion Mutations, Egfr-Mutated NsclcPhase IRecruitingORIC-114 in Combination with Subcutaneous Amivantamab in Patients with EGFR Exon20 Insertion Mutant NSCLCFeb 03, 2025
Oric-944, Abiraterone Acetate 250 Mg Or 500 Mg Tablets, Apalutamide 60 Mg Or 240 Mg Tablets, Darolutamide 300 Mg Tablets, Enzalutamide 40 Mg Capsules Or 40 Mg And 80 Mg TabletsMetastatic Prostate CancerPhase IRecruitingStudy of ORIC-944 in Patients With Metastatic Prostate CancerJun 07, 2022
Chemotherapy Drug, Oric-114Solid Tumorsphase1AndPhase2RecruitingStudy of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 AlterationMar 24, 2022
Oric-533Relapsed Or Refractory Multiple MyelomaPhase ICompletedStudy of ORIC-533 in Relapsed or Refractory Multiple MyelomaFeb 02, 2022―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Oric Pharmaceuticals Inc (ORIC) have in its pipeline
Oric Pharmaceuticals ORIC is currently developing the following drugs: Docetaxel, Enzalutamide, Darolutamide, Rinzimetostat, Taxotere, Oric-944, Oric-114 Dose 1 + Amivantamab, Oric-114 Dose 2 + Amivantamab, Oric-114 Dose 3 + Amivantamab, Oric-944, Abiraterone Acetate 250 Mg Or 500 Mg Tablets, Apalutamide 60 Mg Or 240 Mg Tablets, Darolutamide 300 Mg Tablets, Enzalutamide 40 Mg Capsules Or 40 Mg And 80 Mg Tablets, Chemotherapy Drug, Oric-114, Oric-533. These drug candidates are in various stages of clinical development as the company works toward FDA approval.